These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 17675185)

  • 41. Induction of humoral and cellular immune responses against hepatitis C virus by vaccination with replicon particles derived from Sindbis-like virus XJ-160.
    Zhu W; Fu J; Lu J; Deng Y; Wang H; Wei Y; Deng L; Tan W; Liang G
    Arch Virol; 2013 May; 158(5):1013-9. PubMed ID: 23250650
    [TBL] [Abstract][Full Text] [Related]  

  • 42. HCV-NS3 Th1 minigene vaccine based on invariant chain CLIP genetic substitution enhances CD4(+) Th1 cell responses in vivo.
    Gao M; Wang HP; Wang YN; Zhou Y; Wang QL
    Vaccine; 2006 Jun; 24(26):5491-7. PubMed ID: 16725235
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Enhancing the potency of HBV DNA vaccines using fusion genes of HBV-specific antigens and the N-terminal fragment of gp96.
    Yan J; Liu X; Wang Y; Jiang X; Liu H; Wang M; Zhu X; Wu M; Tien P
    J Gene Med; 2007 Feb; 9(2):107-21. PubMed ID: 17256801
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hot-spot mutations in hepatitis B virus core gene: eliciting or evading immune clearance?
    Liu Z; Luo K; He H; Hou J
    J Viral Hepat; 2005 Mar; 12(2):146-53. PubMed ID: 15720529
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nucleic acid vaccines against hepatitis viruses.
    Howard CR; Gray L; D'Mello F; Christopher J; Craske J
    Dev Biol Stand; 1998; 92():157-62. PubMed ID: 9554270
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Development of a heterologous, multigenotype vaccine against hepatitis C virus infection.
    Encke J; Radunz W; Eisenbach C; Geib J; Gehrke S; Pfaff E; Stremmel W
    Eur J Clin Invest; 2007 May; 37(5):396-406. PubMed ID: 17461986
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparative immunogenicity analysis of modified vaccinia Ankara vectors expressing native or modified forms of hepatitis C virus E1 and E2 glycoproteins.
    Abraham JD; Himoudi N; Kien F; Berland JL; Codran A; Bartosch B; Baumert T; Paranhos-Baccala G; Schuster C; Inchauspé G; Kieny MP
    Vaccine; 2004 Sep; 22(29-30):3917-28. PubMed ID: 15364440
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Enhanced protective immunity against H5N1 influenza virus challenge by vaccination with DNA expressing a chimeric hemagglutinin in combination with an MHC class I-restricted epitope of nucleoprotein in mice.
    Tao P; Luo M; Pan R; Ling D; Zhou S; Tien P; Pan Z
    Antiviral Res; 2009 Mar; 81(3):253-60. PubMed ID: 19135483
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Deletion of the single putative N-glycosylation site of the porcine circovirus type 2 Cap protein enhances specific immune responses by DNA immunisation in mice.
    Gu J; Cao R; Zhang Y; Lian X; Ishag H; Chen P
    Vet J; 2012 Jun; 192(3):385-9. PubMed ID: 22015141
    [TBL] [Abstract][Full Text] [Related]  

  • 50. HIV-1 DNA vaccine efficacy is enhanced by coadministration with plasmid encoding IFN-alpha.
    Jiang W; Ren L; Jin N
    J Virol Methods; 2007 Dec; 146(1-2):266-73. PubMed ID: 17868910
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The ability of Hepatitis B surface antigen DNA vaccine to elicit cell-mediated immune responses, but not antibody responses, was affected by the deglysosylation of S antigen.
    Xing Y; Huang Z; Lin Y; Li J; Chou TH; Lu S; Wang S
    Vaccine; 2008 Sep; 26(40):5145-52. PubMed ID: 18462847
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Activation of refractory T cell responses against hepatitis C virus core protein by ablation of interfering hydrophobic domains.
    Andersson HA; Singh RA; Barry MA
    Mol Ther; 2006 Feb; 13(2):338-46. PubMed ID: 16242998
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immune responses to recombinant Mycobacterium smegmatis expressing fused core protein and preS1 peptide of hepatitis B virus in mice.
    Yue Q; Hu X; Yin W; Xu X; Wei S; Lei Y; Lü X; Yang J; Su M; Xu Z; Hao X
    J Virol Methods; 2007 Apr; 141(1):41-8. PubMed ID: 17197041
    [TBL] [Abstract][Full Text] [Related]  

  • 54. HCV E2 glycoprotein: mutagenesis of N-linked glycosylation sites and its effects on E2 expression and processing.
    Slater-Handshy T; Droll DA; Fan X; Di Bisceglie AM; Chambers TJ
    Virology; 2004 Feb; 319(1):36-48. PubMed ID: 14967486
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Oligomerization of hepatitis C virus core protein is crucial for interaction with the cytoplasmic domain of E1 envelope protein.
    Nakai K; Okamoto T; Kimura-Someya T; Ishii K; Lim CK; Tani H; Matsuo E; Abe T; Mori Y; Suzuki T; Miyamura T; Nunberg JH; Moriishi K; Matsuura Y
    J Virol; 2006 Nov; 80(22):11265-73. PubMed ID: 16971440
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Augmented humoral and cellular immune responses to hepatitis B DNA vaccine adsorbed onto cationic microparticles.
    He X; Jiang L; Wang F; Xiao Z; Li J; Liu LS; Li D; Ren D; Jin X; Li K; He Y; Shi K; Guo Y; Zhang Y; Sun S
    J Control Release; 2005 Oct; 107(2):357-72. PubMed ID: 16099068
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunogenicity of the highly pathogenic porcine reproductive and respiratory syndrome virus GP5 protein encoded by a synthetic ORF5 gene.
    Li B; Xiao S; Wang Y; Xu S; Jiang Y; Chen H; Fang L
    Vaccine; 2009 Mar; 27(13):1957-63. PubMed ID: 19368777
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunization with plasmid DNA encoding a truncated, secreted form of the bovine viral diarrhea virus E2 protein elicits strong humoral and cellular immune responses.
    Liang R; van den Hurk JV; Zheng C; Yu H; Pontarollo RA; Babiuk LA; van Drunen Littel-van den Hurk S
    Vaccine; 2005 Nov; 23(45):5252-62. PubMed ID: 16154245
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immune selection and genetic sequence variation in core and envelope regions of hepatitis C virus.
    Christie JM; Chapel H; Chapman RW; Rosenberg WM
    Hepatology; 1999 Oct; 30(4):1037-44. PubMed ID: 10498657
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immunization with pseudotype baculovirus expressing envelope protein of Japanese encephalitis virus elicits protective immunity in mice.
    Li Y; Ye J; Cao S; Xiao S; Zhao Q; Liu X; Jin M; Chen H
    J Gene Med; 2009 Jan; 11(1):57-65. PubMed ID: 19006097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.